Numida meleagris isolate 19003 breed g44 Domestic line chromosome 25, NumMel1.0, whole genome shotgun sequence.
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Archelosauria; Archosauria; Dinosauria; Saurischia; Theropoda; Coelurosauria; Aves; Neognathae; Galloanserae; Galliformes; Numididae; Numida.
REFSEQ INFORMATION: The reference sequence is identical to\nCM007838.2.\nAssembly name: NumMel1.0\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the INRA on 2017/06/01. The\noriginal whole-genome shotgun project has the accession\nMTSP00000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: INRA\nAssembly Date :: JUL-2013\nAssembly Method :: AllPaths v. July-2013\nAssembly Name :: NumMel1.0\nReference-guided Assembly :: Gallus_gallus-5.0 (GCF_000002315.4)\nGenome Coverage :: 100.0x\nSequencing Technology :: Illumina HiSeq\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Version :: Numida meleagris Annotation Release\n 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 7.4\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
lymphoid-restricted membrane protein-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
microtubule associated monooxygenase, calponin and LIM domain containing 1, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
microtubule associated monooxygenase, calponin and LIM domain containing 1, transcript variant X7
microtubule associated monooxygenase, calponin and LIM domain containing 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
microtubule associated monooxygenase, calponin and LIM domain containing 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
microtubule associated monooxygenase, calponin and LIM domain containing 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
microtubule associated monooxygenase, calponin and LIM domain containing 1, transcript variant X1
microtubule associated monooxygenase, calponin and LIM domain containing 1, transcript variant X3
microtubule associated monooxygenase, calponin and LIM domain containing 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
F-actin-methionine sulfoxide oxidase MICAL1 isoform X2
F-actin-methionine sulfoxide oxidase MICAL1 isoform X1
microtubule associated monooxygenase, calponin and LIM domain containing 1, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
F-actin-methionine sulfoxide oxidase MICAL1 isoform X3
sphingomyelin phosphodiesterase 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
sphingomyelin phosphodiesterase 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
TEA domain transcription factor 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
TEA domain transcription factor 3, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
TEA domain transcription factor 3, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
TEA domain transcription factor 3, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
TEA domain transcription factor 3, transcript variant X1
TEA domain transcription factor 3, transcript variant X4
TEA domain transcription factor 3, transcript variant X3
TEA domain transcription factor 3, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
TEA domain transcription factor 3, transcript variant X9
transcriptional enhancer factor TEF-5 isoform X6
transcriptional enhancer factor TEF-5 isoform X5
transcriptional enhancer factor TEF-5 isoform X2
transcriptional enhancer factor TEF-5 isoform X7
transcriptional enhancer factor TEF-5 isoform X4
transcriptional enhancer factor TEF-5 isoform X3
transcriptional enhancer factor TEF-5 isoform X1
transcriptional enhancer factor TEF-5 isoform X8
transcriptional enhancer factor TEF-5 isoform X9
tubby like protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
tubby like protein 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
tubby like protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
tubby like protein 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
FK506 binding protein 5, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
FK506 binding protein 5, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
FK506 binding protein 5, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
peptidyl-prolyl cis-trans isomerase FKBP5 isoform X3
peptidyl-prolyl cis-trans isomerase FKBP5 isoform X1
peptidyl-prolyl cis-trans isomerase FKBP5 isoform X2
armadillo repeat containing 12, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
armadillo repeat containing 12, transcript variant X1
armadillo repeat-containing protein 12 isoform X1
armadillo repeat-containing protein 12 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
tetraspan membrane protein of hair cell stereocilia
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
solute carrier family 26 member 8, transcript variant X19
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
solute carrier family 26 member 8, transcript variant X18
solute carrier family 26 member 8, transcript variant X16
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
solute carrier family 26 member 8, transcript variant X14
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
solute carrier family 26 member 8, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
solute carrier family 26 member 8, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
solute carrier family 26 member 8, transcript variant X9
solute carrier family 26 member 8, transcript variant X3
solute carrier family 26 member 8, transcript variant X1
solute carrier family 26 member 8, transcript variant X6
solute carrier family 26 member 8, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
solute carrier family 26 member 8, transcript variant X5
solute carrier family 26 member 8, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
solute carrier family 26 member 8, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
solute carrier family 26 member 8, transcript variant X13
solute carrier family 26 member 8, transcript variant X20
solute carrier family 26 member 8, transcript variant X17
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
solute carrier family 26 member 8, transcript variant X15
solute carrier family 26 member 8, transcript variant X12
solute carrier family 26 member 8, transcript variant X11
mitogen-activated protein kinase 14, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 40 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
mitogen-activated protein kinase 14, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
mitogen-activated protein kinase 14 isoform X1
mitogen-activated protein kinase 14 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 50 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
bromodomain and PHD finger containing 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
bromodomain and PHD finger containing 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
bromodomain and PHD finger containing 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
bromodomain and PHD finger containing 3, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
bromodomain and PHD finger containing 3, transcript variant X6
bromodomain and PHD finger containing 3, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
bromodomain and PHD finger containing 3, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
bromodomain and PHD finger containing 3, transcript variant X11
bromodomain and PHD finger containing 3, transcript variant X9
bromodomain and PHD finger containing 3, transcript variant X12
bromodomain and PHD finger containing 3, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
bromodomain and PHD finger containing 3, transcript variant X13
bromodomain and PHD finger containing 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
bromodomain and PHD finger containing 3, transcript variant X14
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
bromodomain and PHD finger containing 3, transcript variant X15
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
bromodomain and PHD finger-containing protein 3 isoform X3
bromodomain and PHD finger-containing protein 3 isoform X1
bromodomain and PHD finger-containing protein 3 isoform X2
TBC1 domain family member 22B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
TBC1 domain family member 22B, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
TBC1 domain family member 22B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
TBC1 domain family member 22B isoform X1
TBC1 domain family member 22B isoform X3
TBC1 domain family member 22B isoform X2
Pim-1 proto-oncogene, serine/threonine kinase
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
calcium voltage-gated channel subunit alpha1 S, transcript variant X2
calcium voltage-gated channel subunit alpha1 S, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
calcium voltage-gated channel subunit alpha1 S, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
calcium voltage-gated channel subunit alpha1 S, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
calcium voltage-gated channel subunit alpha1 S, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
calcium voltage-gated channel subunit alpha1 S, transcript variant X8
voltage-dependent L-type calcium channel subunit alpha-1S isoform X2
calcium voltage-gated channel subunit alpha1 S, transcript variant X1
calcium voltage-gated channel subunit alpha1 S, transcript variant X7
calcium voltage-gated channel subunit alpha1 S, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
calcium voltage-gated channel subunit alpha1 S, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
voltage-dependent L-type calcium channel subunit alpha-1S isoform X1
voltage-dependent L-type calcium channel subunit alpha-1S isoform X3
voltage-dependent L-type calcium channel subunit alpha-1S isoform X5
voltage-dependent L-type calcium channel subunit alpha-1S isoform X4
kinesin family member 21B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
kinesin family member 21B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 3 bases in 3 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 3 bases in 3 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: prosaposin receptor GPR37L1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
protein tyrosine phosphatase, non-receptor type 7, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
protein tyrosine phosphatase, non-receptor type 7, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
tyrosine-protein phosphatase non-receptor type 7 isoform X2
tyrosine-protein phosphatase non-receptor type 7 isoform X1
receptor-type tyrosine-protein phosphatase V-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
receptor-type tyrosine-protein phosphatase V-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
receptor-type tyrosine-protein phosphatase V-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
receptor-type tyrosine-protein phosphatase V-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
receptor-type tyrosine-protein phosphatase V-like isoform X1
receptor-type tyrosine-protein phosphatase V-like isoform X2
receptor-type tyrosine-protein phosphatase V-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
receptor-type tyrosine-protein phosphatase V-like isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
leucine rich repeat containing G protein-coupled receptor 6, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
leucine-rich repeat-containing G-protein coupled receptor 6 isoform X1
leucine rich repeat containing G protein-coupled receptor 6, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
leucine-rich repeat-containing G-protein coupled receptor 6 isoform X2
zinc finger CCCH-type containing 11A, transcript variant X1
zinc finger CCCH-type containing 11A, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
zinc finger CCCH-type containing 11A, transcript variant X2
zinc finger CCCH-type containing 11A, transcript variant X4
zinc finger CCCH-type containing 11A, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
zinc finger CCCH-type containing 11A, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
zinc finger CCCH-type containing 11A, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
zinc finger CCCH domain-containing protein 11A isoform X1
zinc finger CCCH domain-containing protein 11A isoform X3
zinc finger CCCH domain-containing protein 11A isoform X2
negative elongation factor complex member E, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
negative elongation factor complex member E, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
kelch like family member 12, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
kelch like family member 12, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 48 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
similar to RNA sequence (same species):INSD:GBYG01001123.1
annotated by transcript or proteomic data
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 144 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: added 138 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon.
similar to RNA sequence (same species):INSD:GBYG01014767.1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 161 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: added 161 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon.
leucine zipper like transcription regulator 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
leucine zipper like transcription regulator 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
leucine zipper like transcription regulator 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
leucine-zipper-like transcriptional regulator 1 isoform X1
leucine-zipper-like transcriptional regulator 1 isoform X3
leucine-zipper-like transcriptional regulator 1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 75% coverage of the annotated genomic feature by RNAseq alignments
translation initiation factor IF-2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
translation initiation factor IF-2-like, transcript variant X1
uncharacterized protein LOC110388181 isoform X1
uncharacterized protein LOC110388181 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 88% coverage of the annotated genomic feature by RNAseq alignments
neuron navigator 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
neuron navigator 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
similar to RNA sequence (same species):INSD:GBYG01011546.1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 115 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
protein phosphatase 1 regulatory subunit 12B, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
protein phosphatase 1 regulatory subunit 12B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
protein phosphatase 1 regulatory subunit 12B, transcript variant X1
protein phosphatase 1 regulatory subunit 12B, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
protein phosphatase 1 regulatory subunit 12B isoform X5
protein phosphatase 1 regulatory subunit 12B isoform X2
protein phosphatase 1 regulatory subunit 12B isoform X1
protein phosphatase 1 regulatory subunit 12B isoform X4
protein phosphatase 1 regulatory subunit 12B, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
protein phosphatase 1 regulatory subunit 12B, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
protein phosphatase 1 regulatory subunit 12B, transcript variant X7
protein phosphatase 1 regulatory subunit 12B isoform X7
protein phosphatase 1 regulatory subunit 12B isoform X8
protein phosphatase 1 regulatory subunit 12B isoform X3
protein phosphatase 1 regulatory subunit 12B, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
protein phosphatase 1 regulatory subunit 12B isoform X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
pleckstrin homology like domain family A member 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
pleckstrin homology-like domain family A member 3
troponin I1, slow skeletal type, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
troponin I, slow skeletal muscle isoform X1
troponin I1, slow skeletal type, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
troponin I, slow skeletal muscle isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 83% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
immunoglobulin-like and fibronectin type III domain containing 1, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
immunoglobulin-like and fibronectin type III domain containing 1, transcript variant X18
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
immunoglobulin-like and fibronectin type III domain containing 1, transcript variant X19
immunoglobulin-like and fibronectin type III domain containing 1, transcript variant X17
immunoglobulin-like and fibronectin type III domain containing 1, transcript variant X15
immunoglobulin-like and fibronectin type III domain containing 1, transcript variant X14
immunoglobulin-like and fibronectin type III domain containing 1, transcript variant X9
immunoglobulin-like and fibronectin type III domain containing 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
immunoglobulin-like and fibronectin type III domain containing 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
immunoglobulin-like and fibronectin type III domain containing 1, transcript variant X16
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
immunoglobulin-like and fibronectin type III domain containing 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
immunoglobulin-like and fibronectin type III domain containing 1, transcript variant X12
immunoglobulin-like and fibronectin type III domain containing 1, transcript variant X11
immunoglobulin-like and fibronectin type III domain containing 1, transcript variant X10
immunoglobulin-like and fibronectin type III domain containing 1, transcript variant X4
immunoglobulin-like and fibronectin type III domain containing 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
immunoglobulin-like and fibronectin type III domain containing 1, transcript variant X7
immunoglobulin-like and fibronectin type III domain containing 1, transcript variant X5
immunoglobulin-like and fibronectin type III domain containing 1, transcript variant X13
immunoglobulin-like and fibronectin type III domain-containing protein 1 isoform X6
immunoglobulin-like and fibronectin type III domain-containing protein 1 isoform X7
immunoglobulin-like and fibronectin type III domain-containing protein 1 isoform X5
immunoglobulin-like and fibronectin type III domain-containing protein 1 isoform X4
immunoglobulin-like and fibronectin type III domain-containing protein 1 isoform X3
immunoglobulin-like and fibronectin type III domain-containing protein 1 isoform X2
immunoglobulin-like and fibronectin type III domain-containing protein 1 isoform X1
immunoglobulin-like and fibronectin type III domain containing 1, transcript variant X20
immunoglobulin-like and fibronectin type III domain-containing protein 1 isoform X8
transmembrane protein 9, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
transmembrane protein 9, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
transmembrane protein 9, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase C, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase C, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase C, transcript variant X3
alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase C, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase C isoform X2
alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase C isoform X1
alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase C isoform X3
transmembrane protein 183A, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
transmembrane protein 183A, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
transmembrane protein 183A, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
PTPRF interacting protein alpha 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
PTPRF interacting protein alpha 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
PTPRF interacting protein alpha 4, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
PTPRF interacting protein alpha 4, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
PTPRF interacting protein alpha 4, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
PTPRF interacting protein alpha 4, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
adenosine receptor A1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
adenosine receptor A1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
myosin binding protein H, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
myosin binding protein H, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
choline/ethanolamine phosphotransferase 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
choline/ethanolamine phosphotransferase 1, transcript variant X2
choline/ethanolamine phosphotransferase 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
choline/ethanolamine phosphotransferase 1, transcript variant X1
choline/ethanolamine phosphotransferase 1, transcript variant X5
choline/ethanolaminephosphotransferase 1 isoform X2
choline/ethanolaminephosphotransferase 1 isoform X1
DNA damage regulated autophagy modulator 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
DNA damage-regulated autophagy modulator protein 2
ligand dependent nuclear receptor interacting factor 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
ligand dependent nuclear receptor interacting factor 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
ligand dependent nuclear receptor interacting factor 1, transcript variant X3
ligand-dependent nuclear receptor-interacting factor 1 isoform X1
ligand-dependent nuclear receptor-interacting factor 1 isoform X2
ligand-dependent nuclear receptor-interacting factor 1 isoform X3
cryptochrome-1-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 40 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
cryptochrome-1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 40 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
cryptochrome-1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 40 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
cryptochrome-1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 40 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
ubiquitin conjugating enzyme E2 T, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
ubiquitin conjugating enzyme E2 T, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
ubiquitin conjugating enzyme E2 T, transcript variant X3
tetraspanin-18-like, transcript variant X3
tetraspanin-18-like, transcript variant X2
tetraspanin-18-like, transcript variant X1
translocase of inner mitochondrial membrane 17A, transcript variant X1
translocase of inner mitochondrial membrane 17A, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
mitochondrial import inner membrane translocase subunit Tim17-A isoform X1
mitochondrial import inner membrane translocase subunit Tim17-A isoform X3
translocase of inner mitochondrial membrane 17A, transcript variant X2
mitochondrial import inner membrane translocase subunit Tim17-A isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
similar to RNA sequence (same species):INSD:GBYG01022349.1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 64 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: added 22 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 98% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized protein C1orf106 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
uncharacterized protein C1orf194 homolog
KIAA1324 ortholog, transcript variant X2
KIAA1324 ortholog, transcript variant X1
UPF0577 protein KIAA1324 homolog isoform X2
UPF0577 protein KIAA1324 homolog isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
cadherin EGF LAG seven-pass G-type receptor 2
similar to RNA sequence (same species):INSD:GBYG01000321.1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 207 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: added 207 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon.
cadherin EGF LAG seven-pass G-type receptor 2-like
similar to RNA sequence (same species):INSD:GBYG01007969.1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 729 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: added 663 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon.
proline and serine rich coiled-coil 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
proline and serine rich coiled-coil 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
proline and serine rich coiled-coil 1, transcript variant X5
proline and serine rich coiled-coil 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
proline and serine rich coiled-coil 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
proline/serine-rich coiled-coil protein 1 isoform X1
proline/serine-rich coiled-coil protein 1 isoform X2
peptidylprolyl isomerase like 1, transcript variant X1
peptidylprolyl isomerase like 1, transcript variant X3
peptidyl-prolyl cis-trans isomerase-like 1 isoform X1
peptidylprolyl isomerase like 1, transcript variant X2
peptidyl-prolyl cis-trans isomerase-like 1 isoform X2
peptidyl-prolyl cis-trans isomerase-like 1 isoform X3
similar to RNA sequence (same species):INSD:GBYG01016333.1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 136 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: added 136 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
similar to RNA sequence (same species):INSD:GBYG01032077.1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 168 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: added 151 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon.
similar to RNA sequence (same species):INSD:GBYG01004380.1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 569 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: added 552 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
G protein subunit alpha i3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 91 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
guanine nucleotide-binding protein G(k) subunit alpha isoform X2
G protein subunit alpha i3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
guanine nucleotide-binding protein G(k) subunit alpha isoform X1
guanine nucleotide-binding protein G(t) subunit alpha-2
similar to RNA sequence (same species):INSD:GBYG01020939.1
similar to RNA sequence (same species):INSD:GBYG01020940.1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 752 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: added 691 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon.
similar to RNA sequence (same species):INSD:GBYG01010952.1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 84 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: added 15 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon.
similar to RNA sequence (same species):INSD:GBYG01012632.1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 136 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: added 108 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon.
S-adenosylhomocysteine hydrolase-like protein 1
striatin interacting protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
striatin-interacting protein 1 isoform X2
striatin interacting protein 1, transcript variant X1
striatin-interacting protein 1 isoform X1
striatin interacting protein 1, transcript variant X3
striatin-interacting protein 1 isoform X3
solute carrier family 6 member 17, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
solute carrier family 6 member 17, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
solute carrier family 6 member 17, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
sodium-dependent neutral amino acid transporter SLC6A17
potassium voltage-gated channel subfamily C member 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
potassium voltage-gated channel subfamily C member 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
potassium voltage-gated channel subfamily C member 4 isoform X2
potassium voltage-gated channel subfamily C member 4 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC110388097, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
uncharacterized LOC110388097, transcript variant X2
solute carrier family 16 member 4, transcript variant X1
solute carrier family 16 member 4, transcript variant X2
monocarboxylate transporter 5 isoform X2
monocarboxylate transporter 5 isoform X1
late endosomal/lysosomal adaptor, MAPK and MTOR activator 5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 62% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins
potassium voltage-gated channel subfamily A member 10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 47 Proteins, and 89% coverage of the annotated genomic feature by RNAseq alignments
potassium voltage-gated channel subfamily A member 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 51 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
potassium voltage-gated channel subfamily A member 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 51 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
potassium voltage-gated channel subfamily A member 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 51 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
potassium voltage-gated channel subfamily A member 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 51 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
potassium voltage-gated channel subfamily A member 2
uncharacterized LOC110388100, transcript variant X2
uncharacterized LOC110388100, transcript variant X1
potassium voltage-gated channel subfamily A member 3-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 47 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
patatin-like phospholipase domain-containing protein 1
patatin like phospholipase domain containing 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 90% coverage of the annotated genomic feature by RNAseq alignments
apoptosis facilitator Bcl-2-like protein 14
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
potassium channel tetramerization domain containing 20, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
potassium channel tetramerization domain containing 20, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
potassium channel tetramerization domain containing 20, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
potassium channel tetramerization domain containing 20, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
potassium channel tetramerization domain containing 20, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
potassium channel tetramerization domain containing 20, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
BTB/POZ domain-containing protein KCTD20 isoform X1
BTB/POZ domain-containing protein KCTD20 isoform X2
potassium channel tetramerization domain containing 20, transcript variant X7
potassium channel tetramerization domain containing 20, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
BTB/POZ domain-containing protein KCTD20 isoform X5
BTB/POZ domain-containing protein KCTD20 isoform X3
potassium channel tetramerization domain containing 20, transcript variant X8
BTB/POZ domain-containing protein KCTD20 isoform X4
serine/threonine kinase 38, transcript variant X1
serine/threonine kinase 38, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
serine and arginine rich splicing factor 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
RAB44, member RAS oncogene family, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
RAB44, member RAS oncogene family, transcript variant X2
bombesin receptor-activated protein C6orf89 homolog
peptidase inhibitor 16, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
peptidase inhibitor 16, transcript variant X2
uncharacterized LOC110388096, transcript variant X6
uncharacterized LOC110388096, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
uncharacterized LOC110388096, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
uncharacterized LOC110388096, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
uncharacterized LOC110388096, transcript variant X2
uncharacterized LOC110388096, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
small nuclear ribonucleoprotein polypeptide E
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
uncharacterized LOC110388101, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
uncharacterized LOC110388101, transcript variant X2
uncharacterized LOC110388101, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
pleckstrin homology domain containing A6, transcript variant X13
pleckstrin homology domain containing A6, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
pleckstrin homology domain containing A6, transcript variant X1
pleckstrin homology domain containing A6, transcript variant X8
pleckstrin homology domain containing A6, transcript variant X6
pleckstrin homology domain containing A6, transcript variant X5
pleckstrin homology domain containing A6, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
pleckstrin homology domain containing A6, transcript variant X4
pleckstrin homology domain containing A6, transcript variant X7
pleckstrin homology domain containing A6, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
pleckstrin homology domain containing A6, transcript variant X12
pleckstrin homology domain containing A6, transcript variant X11
pleckstrin homology domain containing A6, transcript variant X10
pleckstrin homology domain containing A6, transcript variant X15
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
pleckstrin homology domain containing A6, transcript variant X14
pleckstrin homology domain-containing family A member 6 isoform X4
pleckstrin homology domain-containing family A member 6 isoform X9
pleckstrin homology domain-containing family A member 6 isoform X10
pleckstrin homology domain-containing family A member 6 isoform X8
pleckstrin homology domain-containing family A member 6 isoform X6
pleckstrin homology domain-containing family A member 6 isoform X5
pleckstrin homology domain-containing family A member 6 isoform X3
pleckstrin homology domain-containing family A member 6 isoform X7
pleckstrin homology domain-containing family A member 6 isoform X2
pleckstrin homology domain-containing family A member 6 isoform X1
pleckstrin homology domain-containing family A member 6 isoform X11
protein phosphatase 1 regulatory subunit 15B, transcript variant X3
protein phosphatase 1 regulatory subunit 15B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
protein phosphatase 1 regulatory subunit 15B, transcript variant X1
protein phosphatase 1 regulatory subunit 15B
phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta, transcript variant X1
phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta
phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta, transcript variant X4
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA lysine (anticodon UUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
MDM4, p53 regulator, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
MDM4, p53 regulator, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
MDM4, p53 regulator, transcript variant X2
MDM4, p53 regulator, transcript variant X5
MDM4, p53 regulator, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
leucine rich repeat neuronal 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
leucine rich repeat neuronal 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 96% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
transmembrane protein 81, transcript variant X5
transmembrane protein 81, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
transmembrane protein 81, transcript variant X2
transmembrane protein 81, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
transmembrane protein 81, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
RB binding protein 5, histone lysine methyltransferase complex subunit, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
RB binding protein 5, histone lysine methyltransferase complex subunit, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
RB binding protein 5, histone lysine methyltransferase complex subunit, transcript variant X2
RB binding protein 5, histone lysine methyltransferase complex subunit, transcript variant X1
retinoblastoma-binding protein 5 isoform X4
retinoblastoma-binding protein 5 isoform X3
retinoblastoma-binding protein 5 isoform X2
retinoblastoma-binding protein 5 isoform X1
dual serine/threonine and tyrosine protein kinase, transcript variant X2
dual serine/threonine and tyrosine protein kinase, transcript variant X1
dual serine/threonine and tyrosine protein kinase isoform X2
dual serine/threonine and tyrosine protein kinase isoform X1
dual serine/threonine and tyrosine protein kinase, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
dual serine/threonine and tyrosine protein kinase isoform X3
transmembrane and coiled-coil domain family 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
transmembrane and coiled-coil domains protein 2 isoform X1
transmembrane and coiled-coil domain family 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
transmembrane and coiled-coil domains protein 2 isoform X3
transmembrane and coiled-coil domain family 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
transmembrane and coiled-coil domains protein 2 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
kelch domain containing 8A, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
kelch domain containing 8A, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
transfer RNA tryptophan (anticodon CCA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
uncharacterized LOC110388258, transcript variant X2
uncharacterized LOC110388258, transcript variant X4
uncharacterized LOC110388258, transcript variant X6
uncharacterized LOC110388258, transcript variant X1
uncharacterized LOC110388258, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
uncharacterized LOC110388258, transcript variant X5
cyclin dependent kinase 18, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
cyclin dependent kinase 18, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
major facilitator superfamily domain containing 4A
major facilitator superfamily domain-containing protein 4A
ELK4, ETS transcription factor, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
ELK4, ETS transcription factor, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
solute carrier family 45 member 3, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
solute carrier family 45 member 3, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
solute carrier family 45 member 3, transcript variant X1
solute carrier family 45 member 3, transcript variant X4
solute carrier family 45 member 3, transcript variant X2
solute carrier family 45 member 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
solute carrier family 45 member 3, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
nuclear casein kinase and cyclin dependent kinase substrate 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
nuclear casein kinase and cyclin dependent kinase substrate 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
nuclear casein kinase and cyclin dependent kinase substrate 1, transcript variant X3
nuclear ubiquitous casein and cyclin-dependent kinase substrate 1 isoform X1
nuclear ubiquitous casein and cyclin-dependent kinase substrate 1 isoform X3
nuclear ubiquitous casein and cyclin-dependent kinase substrate 1 isoform X2
similar to RNA sequence (same species):INSD:GBYG01029153.1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 113 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
solute carrier family 41 member 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
solute carrier family 41 member 1, transcript variant X2
peptidase M20 domain containing 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
N-fatty-acyl-amino acid synthase/hydrolase PM20D1 isoform X1
peptidase M20 domain containing 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
N-fatty-acyl-amino acid synthase/hydrolase PM20D1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
chromosome 25 C1orf186 homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized protein C1orf186 homolog isoform X1
chromosome 25 C1orf186 homolog, transcript variant X3
chromosome 25 C1orf186 homolog, transcript variant X2
uncharacterized protein C1orf186 homolog isoform X2
uncharacterized protein C1orf186 homolog isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
family with sequence similarity 72 member A
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
SLIT-ROBO Rho GTPase activating protein 2, transcript variant X2
SLIT-ROBO Rho GTPase activating protein 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
SLIT-ROBO Rho GTPase activating protein 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
SLIT-ROBO Rho GTPase activating protein 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
SLIT-ROBO Rho GTPase activating protein 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
SLIT-ROBO Rho GTPase activating protein 2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
SLIT-ROBO Rho GTPase activating protein 2, transcript variant X8
SLIT-ROBO Rho GTPase-activating protein 2 isoform X1
SLIT-ROBO Rho GTPase-activating protein 2 isoform X4
SLIT-ROBO Rho GTPase-activating protein 2 isoform X2
SLIT-ROBO Rho GTPase-activating protein 2 isoform X5
SLIT-ROBO Rho GTPase-activating protein 2 isoform X3
SLIT-ROBO Rho GTPase-activating protein 2 isoform X7
SLIT-ROBO Rho GTPase activating protein 2, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
SLIT-ROBO Rho GTPase-activating protein 2 isoform X6
inhibitor of nuclear factor kappa B kinase subunit epsilon, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
inhibitor of nuclear factor kappa B kinase subunit epsilon, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
inhibitor of nuclear factor kappa-B kinase subunit epsilon isoform X1
inhibitor of nuclear factor kappa-B kinase subunit epsilon isoform X2
inhibitor of nuclear factor kappa B kinase subunit epsilon, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
inhibitor of nuclear factor kappa-B kinase subunit epsilon isoform X3
Ras association domain family member 5, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
ras association domain-containing protein 5 isoform X1
Ras association domain family member 5, transcript variant X2
ras association domain-containing protein 5 isoform X2
eukaryotic translation initiation factor 2D
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
dual specificity tyrosine phosphorylation regulated kinase 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
dual specificity tyrosine-phosphorylation-regulated kinase 3
mitogen-activated protein kinase-activated protein kinase 2
similar to RNA sequence (same species):INSD:GBYG01013457.1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 52 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: added 52 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 11 Proteins, and 82% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 90% coverage of the annotated genomic feature by RNAseq alignments
polymeric immunoglobulin receptor-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
polymeric immunoglobulin receptor-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
polymeric immunoglobulin receptor-like isoform X1
polymeric immunoglobulin receptor-like isoform X2
chromosome 25 C1orf116 homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
chromosome 25 C1orf116 homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
specifically androgen-regulated gene protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
6-phosphofructo-2-kinase/fructose-2, 6-biphosphatase 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
6-phosphofructo-2-kinase/fructose-2, 6-biphosphatase 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
6-phosphofructo-2-kinase/fructose-2, 6-biphosphatase 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
6-phosphofructo-2-kinase/fructose-2, 6-biphosphatase 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
6-phosphofructo-2-kinase/fructose-2, 6-biphosphatase 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
6-phosphofructo-2-kinase/fructose-2, 6-biphosphatase 2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
6-phosphofructo-2-kinase/fructose-2, 6-biphosphatase 2, transcript variant X7
6-phosphofructo-2-kinase/fructose-2, 6-biphosphatase 2, transcript variant X8
6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase 2 isoform X2
6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase 2 isoform X4
6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase 2 isoform X5
6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase 2 isoform X1
6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase 2 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
complement decay-accelerating factor-like, transcript variant X1
complement decay-accelerating factor-like, transcript variant X3
complement decay-accelerating factor-like, transcript variant X2
complement decay-accelerating factor-like, transcript variant X4
complement decay-accelerating factor-like, transcript variant X5
complement decay-accelerating factor-like, transcript variant X6
complement decay-accelerating factor-like, transcript variant X8
complement decay-accelerating factor-like isoform X2
complement decay-accelerating factor-like, transcript variant X7
complement decay-accelerating factor-like isoform X1
complement receptor type 1-like, transcript variant X2
complement receptor type 1-like, transcript variant X3
complement receptor type 1-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
complement receptor type 1-like, transcript variant X1
complement receptor type 1-like isoform X1
complement receptor type 1-like isoform X2
complement receptor type 1-like isoform X3
complement C3b/C4b receptor 1 (Knops blood group)
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
hematopoietic progenitor cell antigen CD34 isoform X5
hematopoietic progenitor cell antigen CD34 isoform X4
hematopoietic progenitor cell antigen CD34 isoform X2
hematopoietic progenitor cell antigen CD34 isoform X1
hematopoietic progenitor cell antigen CD34 isoform X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
hematopoietic progenitor cell antigen CD34 isoform X3
hematopoietic progenitor cell antigen CD34 isoform X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
calcium/calmodulin dependent protein kinase IG
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized LOC110388299, transcript variant X1
uncharacterized LOC110388299, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
calcium/calmodulin-dependent protein kinase type 1G
hydroxysteroid 11-beta dehydrogenase 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
hydroxysteroid 11-beta dehydrogenase 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
corticosteroid 11-beta-dehydrogenase isozyme 1 isoform X1
corticosteroid 11-beta-dehydrogenase isozyme 1 isoform X2
corticosteroid 11-beta-dehydrogenase isozyme 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
TRAF3 interacting protein 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
TRAF3 interacting protein 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
TRAF3 interacting protein 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
TRAF3 interacting protein 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
TRAF3 interacting protein 3, transcript variant X7
TRAF3 interacting protein 3, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
TRAF3 interacting protein 3, transcript variant X8
TRAF3 interacting protein 3, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
TRAF3 interacting protein 3, transcript variant X10
TRAF3 interacting protein 3, transcript variant X6
TRAF3-interacting JNK-activating modulator isoform X1
TRAF3-interacting JNK-activating modulator isoform X3
TRAF3-interacting JNK-activating modulator isoform X4
TRAF3-interacting JNK-activating modulator isoform X5
TRAF3-interacting JNK-activating modulator isoform X6
TRAF3-interacting JNK-activating modulator isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
chromosome 25 C6orf132 homolog, transcript variant X1
chromosome 25 C6orf132 homolog, transcript variant X2
uncharacterized protein C6orf132 homolog isoform X1
uncharacterized protein C6orf132 homolog isoform X2
ATP synthase, H+ transporting, mitochondrial Fo complex subunit B1
ATP synthase F(0) complex subunit B1, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 66 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
family with sequence similarity 212 member B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
family with sequence similarity 212 member B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
probable ATP-dependent RNA helicase DDX20
potassium voltage-gated channel subfamily D member 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
Wnt family member 2B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 61 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Wnt family member 2B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
suppression of tumorigenicity 7 like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
suppression of tumorigenicity 7 like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
suppression of tumorigenicity 7 like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
suppression of tumorigenicity 7 like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
suppressor of tumorigenicity 7 protein-like isoform X3
suppressor of tumorigenicity 7 protein-like isoform X2
suppressor of tumorigenicity 7 protein-like isoform X1
capping actin protein of muscle Z-line alpha subunit 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
uncharacterized LOC110388350, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
uncharacterized LOC110388350, transcript variant X2
Mov10 RISC complex RNA helicase, transcript variant X1
Mov10 RISC complex RNA helicase, transcript variant X2
ras homolog family member C, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 85 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
ras homolog family member C, transcript variant X1
rho-related GTP-binding protein RhoC isoform X1
rho-related GTP-binding protein RhoC isoform X2
protein phosphatase, Mg2+/Mn2+ dependent 1J, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
protein phosphatase, Mg2+/Mn2+ dependent 1J, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
family with sequence similarity 19 member A3, C-C motif chemokine like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
family with sequence similarity 19 member A3, C-C motif chemokine like, transcript variant X1
leucine rich repeats and immunoglobulin like domains 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
leucine-rich repeats and immunoglobulin-like domains protein 2
membrane associated guanylate kinase, WW and PDZ domain containing 3, transcript variant X1
membrane associated guanylate kinase, WW and PDZ domain containing 3, transcript variant X2
membrane associated guanylate kinase, WW and PDZ domain containing 3, transcript variant X6
membrane-associated guanylate kinase, WW and PDZ domain-containing protein 3 isoform X1
membrane-associated guanylate kinase, WW and PDZ domain-containing protein 3 isoform X2
membrane-associated guanylate kinase, WW and PDZ domain-containing protein 3 isoform X6
membrane associated guanylate kinase, WW and PDZ domain containing 3, transcript variant X3
membrane-associated guanylate kinase, WW and PDZ domain-containing protein 3 isoform X3
uncharacterized LOC110388121, transcript variant X1
uncharacterized LOC110388121, transcript variant X2
membrane associated guanylate kinase, WW and PDZ domain containing 3, transcript variant X4
membrane-associated guanylate kinase, WW and PDZ domain-containing protein 3 isoform X4
membrane associated guanylate kinase, WW and PDZ domain containing 3, transcript variant X5
membrane-associated guanylate kinase, WW and PDZ domain-containing protein 3 isoform X5
putative homeodomain transcription factor 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
putative homeodomain transcription factor 1, transcript variant X1
putative homeodomain transcription factor 1, transcript variant X4
putative homeodomain transcription factor 1 isoform X1
putative homeodomain transcription factor 1 isoform X2
putative homeodomain transcription factor 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
protein tyrosine phosphatase, non-receptor type 22, transcript variant X2
protein tyrosine phosphatase, non-receptor type 22, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
tyrosine-protein phosphatase non-receptor type 22
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
adaptor related protein complex 4 beta 1 subunit
DNA cross-link repair 1B, transcript variant X1
DNA cross-link repair 1B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
homeodomain interacting protein kinase 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
homeodomain interacting protein kinase 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
homeodomain interacting protein kinase 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
homeodomain interacting protein kinase 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
homeodomain interacting protein kinase 1, transcript variant X1
homeodomain-interacting protein kinase 1 isoform X1
homeodomain-interacting protein kinase 1 isoform X3
homeodomain-interacting protein kinase 1 isoform X2
homeodomain-interacting protein kinase 1 isoform X4
homeodomain-interacting protein kinase 1 isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
tripartite motif containing 33, transcript variant X3
tripartite motif containing 33, transcript variant X2
tripartite motif containing 33, transcript variant X1
E3 ubiquitin-protein ligase TRIM33 isoform X3
E3 ubiquitin-protein ligase TRIM33 isoform X2
E3 ubiquitin-protein ligase TRIM33 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
DENN domain containing 2C, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
DENN domain containing 2C, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
DENN domain containing 2C, transcript variant X5
DENN domain containing 2C, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
DENN domain containing 2C, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
DENN domain containing 2C, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
DENN domain containing 2C, transcript variant X2
DENN domain-containing protein 2C isoform X3
DENN domain-containing protein 2C isoform X1
DENN domain-containing protein 2C isoform X4
DENN domain-containing protein 2C isoform X2
DENN domain-containing protein 2C isoform X5
adenosine monophosphate deaminase 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
adenosine monophosphate deaminase 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 79 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: bile acid receptor-like
synaptonemal complex protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
synaptonemal complex protein 1, transcript variant X3
synaptonemal complex protein 1, transcript variant X2
synaptonemal complex protein 1 isoform X1
synaptonemal complex protein 1 isoform X2
thyroid stimulating hormone beta, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
thyroid stimulating hormone beta, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
thyroid stimulating hormone beta, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
nerve growth factor, transcript variant X21
nerve growth factor, transcript variant X18
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
nerve growth factor, transcript variant X15
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
nerve growth factor, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
nerve growth factor, transcript variant X13
nerve growth factor, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
nerve growth factor, transcript variant X14
nerve growth factor, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
nerve growth factor, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
nerve growth factor, transcript variant X4
nerve growth factor, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
nerve growth factor, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
nerve growth factor, transcript variant X3
nerve growth factor, transcript variant X16
nerve growth factor, transcript variant X9
nerve growth factor, transcript variant X5
nerve growth factor, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
nerve growth factor, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
nerve growth factor, transcript variant X19
nerve growth factor, transcript variant X17
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
nerve growth factor, transcript variant X20
nerve growth factor, transcript variant X22
probable E3 ubiquitin-protein ligase makorin-1, transcript variant X2
probable E3 ubiquitin-protein ligase makorin-1, transcript variant X3
probable E3 ubiquitin-protein ligase makorin-1, transcript variant X1
probable E3 ubiquitin-protein ligase makorin-1 isoform X2
probable E3 ubiquitin-protein ligase makorin-1 isoform X3
probable E3 ubiquitin-protein ligase makorin-1 isoform X1
peroxisome proliferator activated receptor delta, transcript variant X3
peroxisome proliferator activated receptor delta, transcript variant X1
peroxisome proliferator activated receptor delta, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
peroxisome proliferator-activated receptor delta isoform X2
peroxisome proliferator-activated receptor delta isoform X1
DEF6, guanine nucleotide exchange factor
similar to RNA sequence (same species):INSD:GBYG01018496.1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 153 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: added 96 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon.
differentially expressed in FDCP 6 homolog
zinc finger protein 76, transcript variant X2
zinc finger protein 76, transcript variant X1
zinc finger protein 76, transcript variant X6
zinc finger protein 76, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
zinc finger protein 76, transcript variant X7
zinc finger protein 76, transcript variant X3
zinc finger protein 76, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
signal peptide, CUB domain and EGF like domain containing 3, transcript variant X2
signal peptide, CUB domain and EGF like domain containing 3, transcript variant X5
signal peptide, CUB domain and EGF like domain containing 3, transcript variant X1
signal peptide, CUB domain and EGF like domain containing 3, transcript variant X4
signal peptide, CUB domain and EGF like domain containing 3, transcript variant X3
signal peptide, CUB domain and EGF like domain containing 3, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
signal peptide, CUB domain and EGF like domain containing 3, transcript variant X6
signal peptide, CUB and EGF-like domain-containing protein 3 isoform X5
signal peptide, CUB and EGF-like domain-containing protein 3 isoform X4
signal peptide, CUB and EGF-like domain-containing protein 3 isoform X3
signal peptide, CUB and EGF-like domain-containing protein 3 isoform X2
signal peptide, CUB and EGF-like domain-containing protein 3 isoform X1
signal peptide, CUB and EGF-like domain-containing protein 3 isoform X7
signal peptide, CUB and EGF-like domain-containing protein 3 isoform X6
signal peptide, CUB domain and EGF like domain containing 3, transcript variant X8
ankyrin repeat and sterile alpha motif domain containing 1A, transcript variant X2
ankyrin repeat and sterile alpha motif domain containing 1A, transcript variant X5
ankyrin repeat and SAM domain-containing protein 1A isoform X5
ankyrin repeat and SAM domain-containing protein 1A isoform X2
ankyrin repeat and sterile alpha motif domain containing 1A, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
ankyrin repeat and sterile alpha motif domain containing 1A, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
ankyrin repeat and sterile alpha motif domain containing 1A, transcript variant X1
ankyrin repeat and sterile alpha motif domain containing 1A, transcript variant X4
ankyrin repeat and sterile alpha motif domain containing 1A, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
ankyrin repeat and SAM domain-containing protein 1A isoform X7
ankyrin repeat and SAM domain-containing protein 1A isoform X3
ankyrin repeat and SAM domain-containing protein 1A isoform X4
ankyrin repeat and SAM domain-containing protein 1A isoform X1
ankyrin repeat and SAM domain-containing protein 1A isoform X6
TATA-box binding protein associated factor 11
transcription initiation factor TFIID subunit 11
small nuclear ribonucleoprotein polypeptide C, transcript variant X2
small nuclear ribonucleoprotein polypeptide C, transcript variant X1
U1 small nuclear ribonucleoprotein C isoform X2
U1 small nuclear ribonucleoprotein C isoform X1
uncharacterized protein C6orf106 homolog
SAM pointed domain containing ETS transcription factor, transcript variant X2
SAM pointed domain containing ETS transcription factor, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
SAM pointed domain-containing Ets transcription factor isoform X1
SAM pointed domain-containing Ets transcription factor isoform X2
protein kinase C and casein kinase substrate in neurons 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
protein kinase C and casein kinase substrate in neurons 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
protein kinase C and casein kinase substrate in neurons protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
diphosphoinositol polyphosphate phosphohydrolase 1
high mobility group AT-hook 1, transcript variant X2
similar to RNA sequence (same species):INSD:GBYG01030068.1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 269 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
high mobility group AT-hook 1, transcript variant X1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 269 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 81% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: added 261 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon.
high mobility group protein HMG-I/HMG-Y isoform X2
high mobility group protein HMG-I/HMG-Y isoform X1
glutamate metabotropic receptor 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
glutamate metabotropic receptor 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
metabotropic glutamate receptor 4 isoform X1
glutamate metabotropic receptor 4, transcript variant X3
metabotropic glutamate receptor 4 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 129 Proteins, and 89% coverage of the annotated genomic feature by RNAseq alignments
LEM domain containing 2, transcript variant X1
LEM domain containing 2, transcript variant X2
LEM domain-containing protein 2 isoform X1
LEM domain-containing protein 2 isoform X2
ubiquinol-cytochrome-c reductase complex assembly factor 2
inositol 1,4,5-trisphosphate receptor type 3
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: inositol 1,4,5-trisphosphate receptor type 3
BCL2 antagonist/killer 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
BCL2 antagonist/killer 1, transcript variant X2
bcl-2 homologous antagonist/killer isoform X2
BCL2 antagonist/killer 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
bcl-2 homologous antagonist/killer isoform X1
bcl-2 homologous antagonist/killer isoform X3
translocator protein 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
translocator protein 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
uncharacterized LOC110388334, transcript variant X1
uncharacterized LOC110388334, transcript variant X2
apolipoprotein B mRNA editing enzyme catalytic subunit 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
apolipoprotein B mRNA editing enzyme catalytic subunit 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
apolipoprotein B mRNA editing enzyme catalytic subunit 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
nuclear transcription factor Y subunit alpha, transcript variant X9
nuclear transcription factor Y subunit alpha, transcript variant X5
nuclear transcription factor Y subunit alpha, transcript variant X8
nuclear transcription factor Y subunit alpha, transcript variant X12
nuclear transcription factor Y subunit alpha, transcript variant X1
nuclear transcription factor Y subunit alpha, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
nuclear transcription factor Y subunit alpha, transcript variant X10
nuclear transcription factor Y subunit alpha, transcript variant X14
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
nuclear transcription factor Y subunit alpha, transcript variant X13
nuclear transcription factor Y subunit alpha, transcript variant X15
nuclear transcription factor Y subunit alpha, transcript variant X7
nuclear transcription factor Y subunit alpha, transcript variant X3
nuclear transcription factor Y subunit alpha, transcript variant X2
nuclear transcription factor Y subunit alpha, transcript variant X6
nuclear transcription factor Y subunit alpha, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
nuclear transcription factor Y subunit alpha isoform X1
nuclear transcription factor Y subunit alpha isoform X5
nuclear transcription factor Y subunit alpha isoform X8
nuclear transcription factor Y subunit alpha isoform X9
nuclear transcription factor Y subunit alpha isoform X3
nuclear transcription factor Y subunit alpha isoform X2
nuclear transcription factor Y subunit alpha isoform X4
nuclear transcription factor Y subunit alpha isoform X6
nuclear transcription factor Y subunit alpha isoform X7
nuclear transcription factor Y subunit alpha isoform X10
triggering receptor expressed on myeloid cells 2-like, transcript variant X1
triggering receptor expressed on myeloid cells 2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
triggering receptor expressed on myeloid cells 2-like, transcript variant X3
triggering receptor expressed on myeloid cells 2-like isoform X1
triggering receptor expressed on myeloid cells 2-like isoform X2
uncharacterized LOC110388333, transcript variant X2
uncharacterized LOC110388333, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
transcription factor EB, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
transcription factor EB, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
transcription factor EB, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 86% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
fibroblast growth factor receptor substrate 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
prickle planar cell polarity protein 4, transcript variant X2
prickle planar cell polarity protein 4, transcript variant X1
prickle planar cell polarity protein 4, transcript variant X3
trithorax group protein osa-like, transcript variant X9
trithorax group protein osa-like, transcript variant X2
trithorax group protein osa-like, transcript variant X4
trithorax group protein osa-like, transcript variant X13
trithorax group protein osa-like, transcript variant X10
trithorax group protein osa-like, transcript variant X8
trithorax group protein osa-like, transcript variant X7
trithorax group protein osa-like, transcript variant X6
trithorax group protein osa-like, transcript variant X3
trithorax group protein osa-like, transcript variant X11
trithorax group protein osa-like, transcript variant X5
trithorax group protein osa-like, transcript variant X1
trithorax group protein osa-like, transcript variant X12
trithorax group protein osa-like, transcript variant X14
trithorax group protein osa-like, transcript variant X15
uncharacterized protein LOC110388220 isoform X9
uncharacterized protein LOC110388220 isoform X7
uncharacterized protein LOC110388220 isoform X6
uncharacterized protein LOC110388220 isoform X5
trithorax group protein osa-like isoform X2
uncharacterized protein LOC110388220 isoform X11
uncharacterized protein LOC110388220 isoform X12
translocase of outer mitochondrial membrane 6, transcript variant X2
translocase of outer mitochondrial membrane 6, transcript variant X3
translocase of outer mitochondrial membrane 6, transcript variant X1
mitochondrial import receptor subunit TOM6 homolog
ubiquitin specific peptidase 49, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
ubiquitin specific peptidase 49, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
ubiquitin specific peptidase 49, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
ubiquitin carboxyl-terminal hydrolase 49 isoform X1
ubiquitin specific peptidase 49, transcript variant X4
ubiquitin carboxyl-terminal hydrolase 49 isoform X2
mediator complex subunit 20, transcript variant X1
mediator of RNA polymerase II transcription subunit 20
mediator complex subunit 20, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
TATA-box binding protein associated factor 8, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
transcription initiation factor TFIID subunit 8 isoform X1
TATA-box binding protein associated factor 8, transcript variant X2
transcription initiation factor TFIID subunit 8 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 54% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
similar to RNA sequence (same species):INSD:GBYG01006073.1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 590 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: added 589 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
proline and arginine rich end leucine rich repeat protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
plasma membrane calcium-transporting ATPase 4-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
plasma membrane calcium-transporting ATPase 4-like, transcript variant X5
plasma membrane calcium-transporting ATPase 4-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
plasma membrane calcium-transporting ATPase 4-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
plasma membrane calcium-transporting ATPase 4-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
plasma membrane calcium-transporting ATPase 4-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
plasma membrane calcium-transporting ATPase 4-like isoform X1
plasma membrane calcium-transporting ATPase 4-like isoform X2
plasma membrane calcium-transporting ATPase 4-like isoform X3
AT-rich interactive domain-containing protein 1B-like, transcript variant X2
AT-rich interactive domain-containing protein 1B-like, transcript variant X1
AT-rich interactive domain-containing protein 1B-like, transcript variant X3
AT-rich interactive domain-containing protein 1B-like isoform X1
AT-rich interactive domain-containing protein 1B-like isoform X2